CA2200595A1 - Utilisation de l'amidon dans des applications transdermiques - Google Patents

Utilisation de l'amidon dans des applications transdermiques

Info

Publication number
CA2200595A1
CA2200595A1 CA002200595A CA2200595A CA2200595A1 CA 2200595 A1 CA2200595 A1 CA 2200595A1 CA 002200595 A CA002200595 A CA 002200595A CA 2200595 A CA2200595 A CA 2200595A CA 2200595 A1 CA2200595 A1 CA 2200595A1
Authority
CA
Canada
Prior art keywords
starch
transdermal applications
implants
substantially fully
destructurized starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002200595A
Other languages
English (en)
Other versions
CA2200595C (fr
Inventor
Gijsbertus Gerardus Petrus Van De Wijdeven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INJECTILE TECHNOLOGIES GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2200595A1 publication Critical patent/CA2200595A1/fr
Application granted granted Critical
Publication of CA2200595C publication Critical patent/CA2200595C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002200595A 1994-09-21 1995-09-20 Utilisation de l'amidon dans des applications transdermiques Expired - Fee Related CA2200595C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL9401534 1994-09-21
NL9401534A NL9401534A (nl) 1994-09-21 1994-09-21 Gebruik van zetmeel voor parenterale toepassingen.
PCT/NL1995/000313 WO1996009070A1 (fr) 1994-09-21 1995-09-20 Utilisation de l'amidon dans des applications transdermiques

Publications (2)

Publication Number Publication Date
CA2200595A1 true CA2200595A1 (fr) 1996-03-28
CA2200595C CA2200595C (fr) 2008-06-10

Family

ID=19864679

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002200595A Expired - Fee Related CA2200595C (fr) 1994-09-21 1995-09-20 Utilisation de l'amidon dans des applications transdermiques

Country Status (13)

Country Link
US (1) US6001385A (fr)
EP (2) EP1250936A1 (fr)
JP (1) JPH10505858A (fr)
AT (1) ATE234633T1 (fr)
AU (1) AU711798B2 (fr)
CA (1) CA2200595C (fr)
DE (1) DE69529991T2 (fr)
DK (1) DK0774975T3 (fr)
ES (1) ES2194056T3 (fr)
NL (1) NL9401534A (fr)
NZ (1) NZ293695A (fr)
PT (1) PT774975E (fr)
WO (1) WO1996009070A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0992251A1 (fr) * 1998-10-07 2000-04-12 Isotis B.V. Dispositif pour la régénération osseuse d'un équivalent osseux
GB2379390B (en) * 2001-09-11 2005-01-26 Caretek Medical Ltd A novel drug delivery technology
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
US7615234B2 (en) * 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
US20030159612A1 (en) * 2002-02-28 2003-08-28 Terrance Ziemack Ballistic implant system and methods
EP1354512A1 (fr) * 2002-04-19 2003-10-22 Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.A. Produit à mâcher pour animaux domestiques
US20040202632A1 (en) * 2003-04-10 2004-10-14 Unilever Home & Personal Care Usa, Division Of Conocpo, Inc. Fragranced solid cosmetic compositions based on a starch delivery system
US7133638B2 (en) * 2004-11-18 2006-11-07 Xerox Corporation Scanning method and an image-processing device including the same
GB2422784A (en) * 2005-02-07 2006-08-09 Caretek Medical Ltd Disposable assembly comprising a needle or stylet
US9615851B2 (en) 2005-11-11 2017-04-11 Waveform Technologies, Inc. Method and apparatus for insertion of a sensor
US20070173706A1 (en) * 2005-11-11 2007-07-26 Isense Corporation Method and apparatus for insertion of a sensor
US7294350B2 (en) * 2006-03-21 2007-11-13 Marraccini Philip A Healing powder and method of use thereof
AU2007314150B2 (en) * 2006-11-01 2009-06-04 Smartvet Pty Ltd Delivery system for remote treatment of an animal
GB2446780A (en) 2007-02-22 2008-08-27 Glide Pharmaceutical Technolog An elongate parenteral injection body having an injection point of angle 10 to 40 degrees.
WO2008105662A1 (fr) * 2007-03-01 2008-09-04 Bioneedle Technologies Group B.V. Matériau biodégradable à base d'amidon ouvert
US8486439B2 (en) * 2007-03-01 2013-07-16 Bioneedle Technologies Group B.V. Parenteral formulation
US8793075B2 (en) 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9072799B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8731841B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9060934B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8551505B2 (en) 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050317B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8409376B2 (en) 2008-10-31 2013-04-02 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9072688B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8762067B2 (en) 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US8788211B2 (en) 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US9050070B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US8725420B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8545855B2 (en) 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060926B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US10376213B2 (en) 2009-06-30 2019-08-13 Waveform Technologies, Inc. System, method and apparatus for sensor insertion
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US8875658B2 (en) 2011-11-30 2014-11-04 A.J. Boggs & Company Projectile pet food
GB201317641D0 (en) * 2013-10-05 2013-11-20 Chowdhury Dewan F H Novel solid dosage form
US20250223571A1 (en) 2022-03-30 2025-07-10 Bioneedle Drug Delivery B.V. A process for storing biologically active constructs in a biodegradable material

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1037792A (en) * 1964-03-13 1966-08-03 Konditerskaja Fabrika Im Marat Enteric coated oral vaccines for intestinal infections
US3616758A (en) * 1968-10-24 1971-11-02 Vladil Afanasievich Komarov Shell for the immobilization of animals
US4673438A (en) * 1984-02-13 1987-06-16 Warner-Lambert Company Polymer composition for injection molding
CH671337A5 (fr) * 1984-06-19 1989-08-31 Ceskoslovenska Akademie Ved
JPH01500034A (ja) * 1986-04-10 1989-01-12 ダラテック　プロプライエタリー　リミテッド ワクチンおよび植込剤
GB2206888B (en) * 1987-07-07 1991-02-06 Warner Lambert Co A destructurized starch and a process for making same
AU1589492A (en) * 1991-03-01 1992-10-06 Warner-Lambert Company Starch-based controlled release compositions
AU4378693A (en) * 1992-05-14 1993-12-13 Endocon, Inc. Liquid-containing drug delivery system

Also Published As

Publication number Publication date
JPH10505858A (ja) 1998-06-09
EP0774975B1 (fr) 2003-03-19
WO1996009070A1 (fr) 1996-03-28
DE69529991D1 (de) 2003-04-24
DE69529991T2 (de) 2003-12-11
PT774975E (pt) 2003-08-29
ATE234633T1 (de) 2003-04-15
AU711798B2 (en) 1999-10-21
CA2200595C (fr) 2008-06-10
EP0774975A1 (fr) 1997-05-28
ES2194056T3 (es) 2003-11-16
AU3620095A (en) 1996-04-09
NZ293695A (en) 1999-05-28
EP1250936A1 (fr) 2002-10-23
NL9401534A (nl) 1996-05-01
US6001385A (en) 1999-12-14
DK0774975T3 (da) 2003-07-14

Similar Documents

Publication Publication Date Title
CA2200595A1 (fr) Utilisation de l'amidon dans des applications transdermiques
BG103590A (en) Pesticide 1-arylpyrazols
CA2331446A1 (fr) Gels d'alginate biodegradables a liberation prolongee
CA2191213A1 (fr) Souches de lactobacillus d'origine humaine, leurs compositions et leurs utilisations
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
CA2011171A1 (fr) Poly(esters phosphoriques) biodegradables
ZA981132B (en) Methods, compositions and articles for reducing or preventing the effects of inflammation.
CA2183549A1 (fr) Nitrite acidifie en tant qu'agent antimicrobien
AU8749198A (en) Deodorant and antimicrobial water absorbent, process for the production thereof and absorbent articles
AU2002232479A1 (en) Low-fat nut spread composition and process for making the same
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU2218497A (en) Aqueous fluoropolymer compositions and method of preparing the same
AU5983696A (en) Fragile x related proteins, compositions and methods of maki ng and using the same
AU1703995A (en) Methods for the production of fungal spores and compositions thereof
CA2418167A1 (fr) Compositions et procedes permettant de prevenir ou de reduire le risque ou la frequence des blessures du squelette chez les chevaux
CA2336375A1 (fr) Amidon modifie, stable vis-a-vis du sel
AU4278593A (en) Antimicrobial compositions, process for preparing the same and use
AU2909400A (en) 1-aryl-1,3,5-triazine-4-thione-2,6-diones, production thereof and use thereof as herbicides
EP0475383A3 (en) Polysaccharide composition or polysaccharide having heparinoid activity, process for producing the same, and anticoagulant containing the same as active ingredient
CA2254533A1 (fr) Traitement du prurit
CA2275379A1 (fr) Utilisation du pramipexole pour le traitement du syndrome des jambes sans repos
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
CA2267059A1 (fr) Derives de sordarine
AU3192299A (en) Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
CA2300319A1 (fr) Derives de 4-cyano-4-deformylsordaricine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed